For several years, pharma watchers have witnessed drug pricing grow into a top issue facing the industry, dominating discussion almost daily. The conversation isn’t likely to subside next year, either.
What’s up with the latest Xarelto TV commercial? That’s what the Twitterati are asking this week in a series of tweets and retweets that call out potentially misleading visuals in the Johnson & Johnson drug ad.